Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. May 15, 2023; 15(5): 902-910
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.902
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.902
Figure 1 Chest computed tomography before and after treatment with fruquintinib showed multiple metastases in both lungs.
A-C: A baseline chest computed tomography (CT) scan before fruquintinib treatment on August 24, 2020; D-F: CT after fruquintinib treatment was given for 3 mo (November 30, 2020); G-I: CT after fruquintinib treatment was given for 8 mo (May 31, 2021); J-L: CT after fruquintinib treatment was given for 12 mo (August 31, 2021).
- Citation: Qu FJ, Wu S, Kong Y. Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report. World J Gastrointest Oncol 2023; 15(5): 902-910
- URL: https://www.wjgnet.com/1948-5204/full/v15/i5/902.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i5.902